AstraZeneca Global R&D Building - topping out

Abell Nepp are laboratory planners for AstraZeneca's new £330m Global R&D Centre and Corporate Headquarters at the Cambridge Biomedical Campus.

Herzog & de Meuron is the concept architect for the building with Abell Nepp appointed through the Executive Architect and Engineer, BDP.

The 'topping out' milestone was reached on April 25, 2017 and celebrated by: Pascal Soriot, CEO, AstraZeneca; Mene Pangalos, Executive Vice President, Innovative Medicines and Early Development Biotech Unit; and, Professor Duncan Maskell, Senior Pro-Vice-Chancellor, University of Cambridge. 

April 2017